You are here

  • Home
  • Archive
  • Volume 8, Issue Suppl 3
  • 711 HBM1022, a novel anti-CCR8 antibody depletes tumor-infiltrating regulatory T cells via enhanced ADCC activity, mediates potent anti-tumor activity with Keytruda

Article metrics

Article menu

Download PDFPDF

Regular and young investigator award abstracts
Novel single-agent immunotherapies
711 HBM1022, a novel anti-CCR8 antibody depletes tumor-infiltrating regulatory T cells via enhanced ADCC activity, mediates potent anti-tumor activity with Keytruda

 

Online download statistics by month:

Online download statistics by month: November 2020 to June 2025

AbstractFullPdf
Nov 2020191054
Dec 202030010
Jan 202176027
Feb 202172043
Mar 2021104055
Apr 2021186055
May 2021122034
Jun 20210035
Jul 20210043
Aug 20210052
Sep 20210052
Oct 2021125057
Nov 2021143054
Dec 2021124048
Jan 202286037
Feb 202288027
Mar 202296021
Apr 202298036
May 202260030
Jun 202258023
Jul 202270043
Aug 2022110050
Sep 202276019
Oct 2022102018
Nov 2022128027
Dec 20227208
Jan 202386023
Feb 2023102038
Mar 202350018
Apr 202366015
May 202360012
Jun 202376014
Jul 202376028
Aug 202332016
Sep 202348013
Oct 20233006
Nov 20232805
Dec 20234407
Jan 20241603
Feb 20242004
Mar 202448029
Apr 202436022
May 202443011
Jun 202457010
Jul 202440011
Aug 20245307
Sep 20245007
Oct 202456013
Nov 202460014
Dec 202474017
Jan 20254809
Feb 20256011
Mar 20250010
Apr 2025008
May 2025008
Jun 20251011
Total352301358